Waldencast (NASDAQ:WALD) Shares Down 4.1%

Waldencast plc (NASDAQ:WALDGet Free Report)’s share price was down 4.1% during trading on Wednesday . The stock traded as low as $5.14 and last traded at $5.14. Approximately 1,109 shares traded hands during trading, a decline of 98% from the average daily volume of 69,398 shares. The stock had previously closed at $5.36.

Wall Street Analyst Weigh In

Separately, Telsey Advisory Group dropped their price objective on Waldencast from $12.00 to $10.00 and set an “outperform” rating on the stock in a research report on Friday, March 22nd.

View Our Latest Stock Report on Waldencast

Waldencast Stock Performance

The business has a 50-day moving average of $6.52 and a two-hundred day moving average of $8.25.

Institutional Investors Weigh In On Waldencast

Institutional investors have recently added to or reduced their stakes in the stock. Amalgamated Bank boosted its position in Waldencast by 68.1% during the third quarter. Amalgamated Bank now owns 3,277 shares of the company’s stock valued at $31,000 after purchasing an additional 1,328 shares in the last quarter. Barclays PLC boosted its holdings in Waldencast by 440.0% in the second quarter. Barclays PLC now owns 4,093 shares of the company’s stock worth $31,000 after acquiring an additional 3,335 shares in the last quarter. State Board of Administration of Florida Retirement System acquired a new stake in Waldencast in the third quarter worth about $97,000. Norden Group LLC acquired a new stake in Waldencast in the first quarter worth about $92,000. Finally, SG Americas Securities LLC acquired a new stake in Waldencast in the third quarter worth about $151,000. Institutional investors own 41.97% of the company’s stock.

About Waldencast

(Get Free Report)

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.

Recommended Stories

Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.